Clinical Trial Update: Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim [Phase 3]

View source ↗

Summary

A Phase III trial comparing LA-EP2006 to pegfilgrastim in chemotherapy-induced neutropenia and breast cancer completed with results posted in 2017. The study ev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Neutropenia

Drugs mentioned

• LA-EP2006 (pegfilgrastim)
• Peg-Filgrastim (pegfilgrastim)

Snippet

Sponsor: Sandoz | Conditions: Chemotherapy-induced Neutropenia, Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-06-28